Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases.

MLA

Fukuta, Takanori, et al. “Nelarabine-Induced Myelopathy in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: A Report of Three Cases.” International Journal of Hematology, vol. 117, no. 6, June 2023, pp. 933–40. EBSCOhost, https://doi.org/10.1007/s12185-023-03539-5.

APA

Fukuta, T., Tanaka, T., Hashimoto, T., Isahaya, K., Kubo, Y., Yamano, Y., Satomi, K., Hiraoka, N., Shirakawa, N., Arakawa, A., Ogawa, C., Nishimura, N., Aoki, J., Ito, A., Inamoto, Y., Kim, S.-W., & Fukuda, T. (2023). Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases. International Journal of Hematology, 117(6), 933–940. https://doi.org/10.1007/s12185-023-03539-5

Chicago

Fukuta, Takanori, Takashi Tanaka, Taiki Hashimoto, Kenji Isahaya, Yuko Kubo, Yoshihisa Yamano, Kaishi Satomi, et al. 2023. “Nelarabine-Induced Myelopathy in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: A Report of Three Cases.” International Journal of Hematology 117 (6): 933–40. doi:10.1007/s12185-023-03539-5.